Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock

The current price of CYCCP is 13.00 USD — it has decreased by 26.35% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock stocks are traded under the ticker CYCCP.

CYCCP stock is 40.97% volatile and has beta coefficient of −0.59. Check out the list of the most volatile stocks — is Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock there?

Yes, you can track Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock financials in yearly and quarterly reports right on TradingView.

CYCCP stock has fallen by 26.14% compared to the previous week, the month change is a 27.21% fall, over the last year Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock has showed a 15.91% decrease.

Today Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock has the market capitalization of ‪2.44 M‬, it has decreased by 0.47% over the last week.

Yes, CYCCP dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (TTM)% is 0%. Tracking Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock dividends might help you take more informed decisions.

Like other stocks, CYCCP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock stock right from TradingView charts — choose your broker and connect to your account.

CYCCP reached its all-time high on Mar 7, 2023 with the price of 22.58 USD, and its all-time low was 0.58 USD and was reached on Dec 2, 2008.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock stock shows the neutral signal. See more of Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock EBITDA is ‪−25.82 M‬ USD, and current EBITDA margin is ‪−7.21 K‬%. See more stats in Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock financial statements.